Deer IX & Co. Ltd. - Q4 2020 holdings

Add to watchlist

$200 Million is the total value of Deer IX & Co. Ltd.'s 3 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
NCNO NewNCINO INC$101,827,000–1,562,500
+100.0%
50.91%–
KYMR NewKYMERA THERAPEUTICS INC$97,949,000–1,755,356
+100.0%
48.97%–
DKNG NewDRAFTKINGS INC$254,000–5,463
+100.0%
0.13%–
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Deer IX & Co. L.P. #1
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
KYMERA THERAPEUTICS INC4Q3 202155.3%
NCINO INC3Q2 202150.9%
BRIGHT HEALTH GROUP INC2Q3 202190.3%
VELO3D INC1Q3 202129.4%
OTONOMO TECHNOLOGIES LTD1Q3 20218.6%
SPIRE GLOBAL INC.1Q3 20218.4%
TSCAN THERAPEUTICS INC1Q3 20211.0%
DRAFTKINGS INC1Q4 20200.1%

View Deer IX & Co. Ltd.'s complete holdings history.

Latest significant ownerships (13-D/G)
Deer IX & Co. Ltd. Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Otonomo Technologies Ltd.September 14, 20225,563,5614.2%
TScan Therapeutics, Inc.February 14, 2022691,5053.7%
Velo3D, Inc.October 12, 202116,842,0139.2%

View Deer IX & Co. Ltd.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-NT2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42023-12-19
42023-12-12
13F-NT2023-11-14
42023-09-19
42023-09-15
13F-NT2023-08-14
42023-08-04

View Deer IX & Co. Ltd.'s complete filings history.

All filings

View complete filings history.

Compare quarters

Export Deer IX & Co. Ltd.'s holdings

CSVXLS